Salute e Benessere

Nyxoah Advances Patient Access Strategy through Partnership with the American…

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation First medical device company to become a corporate champion at the ENTerprise Circle levelMont-Saint-Guibert, Belgium – March 25, 2024, 7:05am CET / 2:05am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat...

Valneva Announces Filing of 2023 Universal Registration Document and US Form…

Saint-Herblain (France), March 25, 2024–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 22, 2024, of its 2023 Universal Registration Document (URD) with the French Financial Markets Authority (AMF) under the filing number D.24-0157 and its Form 20-F with the U.S. Securities and Exchange Commission (SEC).Valneva's 2023 Universal Registration Document – available in its entirety in French – includes the Company's 2023...

Sequana Medical announces three month follow-up data from MOJAVE non-randomized…

MOJAVE – US Phase 1/2a study of DSR 2.0 for treatment of heart failure Previously reported strong data maintained after three-months follow-up:Diuretic response remained nearly normalized, with a mean increase of 326% in six-hour urinary sodium excretion vs baselineAll three patients remained on no or low dose loop diuretics, with a reduction of at least 95% vs baselineRandomized cohort of up to 30 additional patients planned to commence following US market approval of...

Ultimovacs ASA: Notice of Annual General Meeting on April 18, 2024

Oslo, March 25, 2024, the Board of Directors hereby calls for the Annual General Meeting of Ultimovacs ASA (the "Company") at 14:00 CET on April 18, 2024.The General Meeting will be held electronically. For participation, please log in athttps://dnb.lumiagm.com/137559337. All documents regarding the Annual General Meeting are available at the Company's website: www.ultimovacs.comFor further information, please seewww.ultimovacs.comor contact: Jónas Einarsson, Chairman of the...

XRP Healthcare Partner with NHS collaborator Isansys Lifecare to Revolutionize…

Isansys Lifecare, under the visionary leadership ofKeith Errey, has distinguished itself in the global healthcare technology market, especially through its successful partnership with the National Health Service (NHS) in the UK, and leading hospitals in Scandinavia andEurope. This collaboration has underscored Isansys' capability to implement scalable and impactful patient monitoring solutions within complex healthcare systems, a precedent that promises significant...

New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to…

PeerLINC will provide practical training and technical assistance to countries to support this objective, via experts from the Philippines and the Department of Health, including Lung Center of the Philippines and the National TB Reference Laboratory (NTRL). The Philippines has successfully and rapidly deployed new treatments through participation in TB Alliance's Leveraging Innovation for Faster TB Treatment (LIFT-TB) initiative. PeerLINC will provide practical training and technical...

Australian Government Grants TB Alliance an Award to Help Bolster Clinical…

"Drug-resistant TB is an increasing threat to the health and well-being both in Australia and in our neighbouring countries, and in many low- and middle-income countries around the world," said the Hon. Pat Conroy, Minister for International Development and the Pacific. "We are proud of our continued support of the work of TB Alliance, and to help in the rollout of the BPaL/M regimens and to support the development of the next generation of new TB treatments. These are important…

BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT

About BioVaxys Technology Corp. About BioVaxys Technology Corp. BioVaxys Technology Corp. ( www.biovaxys.com ), a biopharmaceuticals company registered inBritish Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it's HapTenix© 'neoantigen' tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other...

Vistin Pharma ASA: Mandatory notification of trade

Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA at a price of NOK 22,10 per share. Espen W. Marcussen, Chair of the board in Pactum Vekst AS, is a primary insider and board member of Vistin Pharma ASA. Pactum Vekst AS is fully owned by Pactum AS. The shares in Vistin Pharma are sold to one of Pactum's shareholders, as part of a share buy-back process in Pactum.After the transaction, Pactum Vekst AS owns 2 991 773 shares in Vistin Pharma ASA.Please see...

Alvotech Announces Increase in Number of Own Shares

Alvotech (NASDAQ: ALVO) (the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, has increased the Company´s share capital by an amount of one hundred and thirty thousand (USD 130,000) by issuing thirteen million (13,000,000) ordinary shares. The Company's subsidiary, Alvotech Manco ehf. (the “subsidiary”), has subscribed to all of the newly issued shares for a price of USD 15.98 per share. The shares held by the...

Inventiva announces the schedule of publication and presentation of its 2023…

Daix (France), Long Island City (New York, United States), March 22, 2024– Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), also known as non-alcoholic steatohepatitis (NASH), and other diseases with significant unmet medical needs, today announced that its management team will host a webcast to present the...

Oxurion Receives Transparency Notification from Atlas Special Opportunities…

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – March 22, 2024 – 07:00 PM CETOxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation 1it has received transparency notifications as follows: Oxurion received a transparency notification on March 20, 2024, from Atlas Special Opportunities, LLC indicating that as of March 14, 2024, it...

yoose®️ 2024 Spring Launch: Mini Shaver for Next Generation

yoose's first 3-in-1 men's grooming kit, the MINI Cube series, caters to shaving, nose hair trimming, and facial cleansing needs. Transitioning from individual items such as cigarettes, mobile phones, and car keys to an all-in-one grooming set represents a new trend in essential items for trendy men at home and on the go. With its rounded alloy body and golf ball-sized design, it offers ultimate portability, meeting users' grooming needs whether in the car, on business trips, or during travels…

Aircraft Landing Gears Market worth $9.1 billion by 2028 - Exclusive Report by…

Browse in-depth TOC on "Aircraft Engine Test Cells Market" Browse in-depth TOC on "Aircraft Engine Test Cells Market" 298 – Tables 71 – Figures 265 – Pages Aircraft Engine Test Cells Market Report Scope: By End User, the aftermarket segment is projected to grow at the second highest CAGR during the forecast period. The aftermarket segment in the aircraft landing gears market is gaining momentum to hold the second highest market share. The aircraft landing gear undergoes...

Ultimovacs ASA: Mandatory notification of trade by primary insider

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. Attachment 20240322 - Ultimovacs Notification of trade - HS - KRT 1500

Lecanemab deliberations at the CHMP regarding the Marketing Authorisation…

The decision is entirely related to procedural reasons at EMA and is not related to the Marketing Authorisation Application (MAA) for lecanemab itself. Eisai will continue to collaborate with EMA during the ongoing review procedure of lecanemab. The decision is entirely related to procedural reasons at EMA and is not related to the Marketing Authorisation Application (MAA) for lecanemab itself. Eisai will continue to collaborate with EMA during the ongoing review procedure of lecanemab...

Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral…

Positive CHMP opinion based on robust Phase III data, including APPLY-PNH, demonstrating superior hemoglobin improvement in the absence of transfusions with Fabhalta compared to anti-C5 therapy 1-5If approved, Fabhalta ®will be the first oral monotherapy available in Europe for the treatment of PNH, a chronic and rare blood disorder, in both complement inhibitor-treated and -naive PNH patients with hemolytic anemia 1 Despite anti-C5 therapy, a large proportion of patients...

OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for…

Ocular Pain Relief showed statistically significant improvement as early as day 15 and the benefit was durable throughout the trial. Conjunctival Staining improved as early as day 29 with a durable benefit throughout the trial.Tear Film Break-up Time showed statistically significant improvement as early as day 15 with the benefit durable for the remainder of the trial.Burning/Stinging, and Blurred Vision improved as early as day 15 and the benefit remained durable throughout the...

Ongoing Fitness Trends Are Driving the Growth of the Health and Fitness Club…

Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19317 Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-19317 One of the key trends in the fitness industry is the growing demand for boutique fitness centers, which cater to individuals seeking a curated workout experience and are willing to pay a premium price for it...

Change in Orion Group Executive Management Board: change in Orion's group-level…

ORION CORPORATIONSTOCK EXCHANGE RELEASE – CHANGES BOARD / MANAGEMENT / AUDITORS 22 MARCH 2024 at 12.30 EET Change in Orion Group Executive Management Board: change in Orion's group-level functions The following change will take place in Orion's group-level functions: the Corporate Strategy and Program Management (CSPMO) unit will become part of the Finance and Corporate Business Development unit.The change will strengthen the steering of the Group and create a more unified...

Frost & Sullivan Launches the 2024 Edition of India Manufacturing Excellence and…

India Manufacturing Excellence Awards (IMEA) India Manufacturing Excellence Awards (IMEA) IMEA honors organizations across automotive, industrial engineering, FMCG, pharmaceutical, healthcare, and metals-based sectors for their manufacturing excellence. Over the past 19 years, IMEA has been instrumental in advancing manufacturing capabilities, optimizing supply chains, and enhancing production systems inIndia. The awards ceremony marks a significant milestone in recognizing the...

Dead Sea Mineral Demand Set to Rise at 8.3% CAGR through 2034 Spurred by…

Key Coverage in Global Dead Sea Mineral Market Report Key Coverage in Global Dead Sea Mineral Market Report Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-19306 Rising demand for Dead Sea minerals can be attributed to several reasons. Firstly, these minerals are well known for their unique and beneficial qualities. They offer numerous health benefits, thereby making them popular ingredients in...

Automotive Ceramics Market worth $3.2 billion by 2028 - Exclusive Report by…

Browse in-depth TOC on "Automotive Ceramics Market". Browse in-depth TOC on "Automotive Ceramics Market". 217 – Tables 38 – Figures 215 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=127800594 "Zirconia Oxide, by material, are expected to be the most significant automotive ceramics market segment during the forecast period." Zirconia oxide holds the most significant shares in the material segment of the automotive ceramics…

The change negotiations concerning Orion's Kuopio plant have been concluded –…

ORION CORPORATIONPRESS RELEASE22 March 2024 at 12.00 EETThe change negotiations concerning Orion's Kuopio plant have been concluded – the company has decided to continue to explore the outsourcing of production at the plantOrion Corporation announced on 19 February 2024 that it was evaluating the possible outsourcing of its pharmaceutical production in Kuopio, part of its Global Operations function, to an entity outside Finland. The related statutory negotiations in accordance with...

Altri Comunicati